Original founders of AyeAI. The team is being restructured. Please visit this page for updates.
Abhishek Choudhary , Founder
Abhishek Choudhary is the founder and managing partner of AyeAI Consulting - a startup developing IaaS for scientific and cognitive computing towards accessible healthcare. He is also the MD of Interglial Healthcare and acting CEO of Vyas Labs. Prior to starting AyeAI, Abhishek worked for IBM for over 7 years as a Senior Architect responsible for seeding and growing Power Hypervisor IO virtualization and firmware from Power 7 to Power 9 processor families, qemu based system simulation, and was one of the founding architects for PowerAI (currently called ‘Watson Machine Learning Accelerator’) In a career of over two decades he conceptualized and built internationally awarded telemedicine devices ( HMSEI / RDK / Dr Rho ), blended reality autonomous vehicles ( TARA ) and cognitive robots ( ANGEL ). He has also worked for Hewlett Packard as a platform architect for software defined networking, a Cummin franchise on industrial automation and intelligent vehicles and a UK based fintech provider on intelligent regulatory reporting. Accomplished innovator with multiple patent filings and publications, he has been a pioneer in inclusive technologies having developed Hindawi Programming System for systems programming in Hindi and other Indian languages. He is multidisciplinary trained in Pre-clinical Medicine, Neural Engineering, Medical Devices Technology, Telemedicine, Remote Diagnostics, Augmented Reality, Robotics & AI (Natural Language Processing, Machine Learning, Deep Learning, Analytics and Data Sciences).Qualifications also include MBA, Law, Clinical Psychology, Linguistics, Philosophy and Genetic Anthropology. He started as a freelancer in 1996 working on embedded systems and has been an Entrepreneur between 2000 - 2006 building medical devices and autonomous robots. His research areas are Brain Computer Interface and Brain Implants (electro-chemical implants for Parkinson's disease, Alzheimer's disease and developmental cognitive disorders), Technological Singularity and Transhumanism.
Dr Srija Katta , Co-Founder
Dr Srija is the Co-Founder of AyeAI Consulting and Heads Company Operations and Pharma lab. She is a Director at Vyas Labs Pvt Ltd and Interglial Healthcare (OPC) Pvt Ltd. She is a passionate Entrepreneur experienced in Startup strategy, New Product Road Map, Requirement Analysis, with skills in Artificial Intelligence for Pharma and Healthcare. She was one among the invitees of Roundtable “Transforming Primary Healthcare – Leveraging Technologies” at NASSCOM Technology and Leadership Forum 2019. She was an invited speaker for IEEE CIS Summer School 2018 and has delivered a handson session on topic “AI in Healthcare” Dr Srija is familiar with Course design, Seminars and Workshop delivery. Dr Srija is a Clinical Pharmacist (Doctor of Pharmacy) by profession, trained in Biz ops like Regulatory Compliance, Banking Operations, HR management, Public Relations, Business development Collaterals design, Awareness and Marketing Campaign design and other technical aspects like Gitops, Website building etc.. She is skilled in Systemic and Conversational Peer Review and has been a Reviewer for a few international conferences and journals including International Society of Pharmacoeconomics and Outcomes Research 6 TH Latin America Conference, Brazil - 2017 and 20th Annual European Congress.-2017. Her professional Interest includes Artificial Intelligence and Insilico based accelerated drug discovery, Medical devices, Digihealth, Telemedicine, IoMT. Research interests include Psychoneuroimmunological studies with respect to human epigenetics and social habits. She aspires for Social Welfare and has conducted various Healthcare Awareness Campaign during her graduation days. She actively coordinates the activities of TWISHA - The Women in Self Health Awareness, a health4all initiative by an NGO, Gramsheel Foundation. She has been one of among the top distinction holder of the prestigious Ashoka Changemaker Intraprenuership - 2018.